Cancer Gene Therapy
Research on cancer gene therapy discussed by scientists at Taipei Medical University, Department of Internal Medicine
Published in Gene Therapy Weekly, February 15th, 2007
Scientists discuss in "Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells" new findings in cancer. According to recent research published in the journal Anti-Cancer Drugs, "C-Myc oncogene is critical for the development of hepatocellular carcinoma. Given the successful use of small-molecule inhibitors on cancers, targeting c-Myc with small-molecule inhibitors represents a promising approach."
"The potential of using small-molecule c-Myc inhibitor, 10058-F4, was evaluated on hepatocellular carcinoma cell lines, HepG2 and Hep3B...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-02-15)
More Articles from Gene Therapy Weekly
- Drug Development
Dual gene therapy suppresses lung cancer in preclinical test - Cancer Gene Therapy
Data on cancer gene therapy detailed by researchers at University of Maryland, Department of Radiation Oncology - Cancer Gene Therapy
Investigators at Queen Mary Hospital zero in on cancer gene therapy - Cancer Gene Therapy
Research conducted at University of Calgary has provided new information about cancer gene therapy - Cancer Gene Therapy
Research from University Medical Center, Department of Neurosurgery has provided new data on cancer gene therapy - Cancer Gene Therapy
Scientists at National Institute on Deafness and Other Communication Disorders report research in cancer gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
